CLINICAL_TRIALS
research
· 2013-08-12
Clinical Trial Update: Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Summary
This entry reports an ongoing Phase 2 clinical trial evaluating Sunitinib given before or after surgery in patients with metastatic renal cell carcinoma (kidney…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gruppo Italiano Carcinoma Renale | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN